Multiple sclerosis tremor: are technical advances enough?

Affiliations

¹ Morton and Gloria Shulman Movement Disorders Centre and the Edmond J Safra Program in Parkinson's Disease, Toronto Western Hospital, University Health Network, Toronto, ON, Canada; Division of Neurology, University of Toronto, Toronto, ON, Canada.
² Morton and Gloria Shulman Movement Disorders Centre and the Edmond J Safra Program in Parkinson's Disease, Toronto Western Hospital, University Health Network, Toronto, ON, Canada; Division of Neurology, University of Toronto, Toronto, ON, Canada; Krembil Research Institute, Toronto, ON, M5T 2S8, Canada. Electronic address: alfonso.fasano@uhn.ca.

Comment

Derrick Soh et al. Lancet Neurol. 2017 Sep.

. 2017 Sep;16(9):678-679.

doi: 10.1016/S1474-4422(17)30198-9. Epub 2017 Jun 20.

¹ Morton and Gloria Shulman Movement Disorders Centre and the Edmond J Safra Program in Parkinson's Disease, Toronto Western Hospital, University Health Network, Toronto, ON, Canada; Division of Neurology, University of Toronto, Toronto, ON, Canada.
² Morton and Gloria Shulman Movement Disorders Centre and the Edmond J Safra Program in Parkinson's Disease, Toronto Western Hospital, University Health Network, Toronto, ON, Canada; Division of Neurology, University of Toronto, Toronto, ON, Canada; Krembil Research Institute, Toronto, ON, M5T 2S8, Canada. Electronic address: alfonso.fasano@uhn.ca.

No abstract available

Comment on

Safety and efficacy of dual-lead thalamic deep brain stimulation for patients with treatment-refractory multiple sclerosis tremor: a single-centre, randomised, single-blind, pilot trial.
Oliveria SF, Rodriguez RL, Bowers D, Kantor D, Hilliard JD, Monari EH, Scott BM, Okun MS, Foote KD. Oliveria SF, et al. Lancet Neurol. 2017 Sep;16(9):691-700. doi: 10.1016/S1474-4422(17)30166-7. Epub 2017 Jun 20. Lancet Neurol. 2017. PMID: 28642125 Clinical Trial.